News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
727,538 Results
Type
Article (43111)
Company Profile (457)
Press Release (683953)
Multimedia
Podcasts (105)
Webinars (20)
Section
Business (209086)
Career Advice (2029)
Deals (36073)
Drug Delivery (108)
Drug Development (83798)
Employer Resources (174)
FDA (16577)
Job Trends (15156)
News (353594)
Policy (33230)
Tag
Academia (2646)
Accelerated approval (18)
Adcomms (28)
Allergies (115)
Alliances (51118)
ALS (137)
Alzheimer's disease (1598)
Antibody-drug conjugate (ADC) (198)
Approvals (16625)
Artificial intelligence (394)
Autoimmune disease (62)
Automation (25)
Bankruptcy (373)
Best Places to Work (11840)
BIOSECURE Act (19)
Biosimilars (144)
Biotechnology (331)
Bladder cancer (120)
Brain cancer (47)
Breast cancer (451)
Cancer (3592)
Cardiovascular disease (304)
Career advice (1705)
Career pathing (33)
CAR-T (224)
CDC (42)
Cell therapy (610)
Cervical cancer (30)
Clinical research (69564)
Collaboration (1298)
Company closure (4)
Compensation (907)
Complete response letters (50)
COVID-19 (2727)
CRISPR (78)
C-suite (543)
Cystic fibrosis (129)
Data (4106)
Decentralized trials (2)
Denatured (34)
Depression (100)
Diabetes (410)
Diagnostics (6578)
Digital health (33)
Diversity (10)
Diversity, equity & inclusion (45)
Drug discovery (186)
Drug pricing (157)
Drug shortages (29)
Duchenne muscular dystrophy (195)
Earnings (89870)
Editorial (49)
Employer branding (21)
Employer resources (151)
Events (118550)
Executive appointments (936)
FDA (18875)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (5)
Frontotemporal dementia (13)
Funding (1174)
Gene editing (164)
Generative AI (26)
Gene therapy (496)
GLP-1 (892)
Government (4684)
Grass and pollen (5)
Guidances (332)
Healthcare (19187)
HIV (44)
Huntington's disease (36)
IgA nephropathy (54)
Immunology and inflammation (214)
Immuno-oncology (16)
Indications (51)
Infectious disease (2936)
Inflammatory bowel disease (174)
Inflation Reduction Act (15)
Influenza (85)
Intellectual property (178)
Interviews (314)
IPO (16895)
IRA (51)
Job creations (3710)
Job search strategy (1437)
Kidney cancer (13)
Labor market (67)
Layoffs (560)
Leadership (25)
Legal (8014)
Liver cancer (86)
Longevity (11)
Lung cancer (513)
Lymphoma (254)
Machine learning (26)
Management (59)
Manufacturing (566)
MASH (127)
Medical device (13731)
Medtech (13750)
Mergers & acquisitions (20023)
Metabolic disorders (1039)
Multiple sclerosis (131)
NASH (19)
Neurodegenerative disease (204)
Neuropsychiatric disorders (54)
Neuroscience (2557)
NextGen: Class of 2025 (6759)
Non-profit (4562)
Now hiring (55)
Obesity (502)
Opinion (255)
Ovarian cancer (121)
Pain (148)
Pancreatic cancer (160)
Parkinson's disease (228)
Partnered (25)
Patents (387)
Patient recruitment (288)
Peanut (53)
People (59545)
Pharmaceutical (85)
Pharmacy benefit managers (23)
Phase I (21840)
Phase II (30705)
Phase III (22653)
Pipeline (2578)
Policy (251)
Postmarket research (2602)
Preclinical (9382)
Press Release (67)
Prostate cancer (185)
Psychedelics (49)
Radiopharmaceuticals (275)
Rare diseases (603)
Real estate (6044)
Recruiting (69)
Regulatory (23805)
Reports (51)
Research institute (2443)
Resumes & cover letters (352)
Rett syndrome (12)
RNA editing (15)
RSV (61)
Schizophrenia (127)
Series A (196)
Series B (147)
Service/supplier (11)
Sickle cell disease (78)
Special edition (24)
Spinal muscular atrophy (154)
Sponsored (35)
Startups (3789)
State (2)
Stomach cancer (15)
Supply chain (92)
Tariffs (78)
The Weekly (69)
Vaccines (905)
Venture capital (64)
Weight loss (330)
Women's health (55)
Worklife (18)
Date
Today (148)
Last 7 days (557)
Last 30 days (2265)
Last 365 days (31499)
2025 (23765)
2024 (36299)
2023 (41016)
2022 (52277)
2021 (56764)
2020 (54920)
2019 (47417)
2018 (35696)
2017 (33027)
2016 (32348)
2015 (38397)
2014 (32189)
2013 (27110)
2012 (29222)
2011 (29866)
2010 (27996)
Location
Africa (742)
Alabama (77)
Alaska (7)
Arizona (272)
Arkansas (14)
Asia (40002)
Australia (6642)
California (9021)
Canada (2757)
China (826)
Colorado (380)
Connecticut (395)
Delaware (240)
Europe (87680)
Florida (1325)
Georgia (294)
Hawaii (2)
Idaho (60)
Illinois (716)
India (40)
Indiana (425)
Iowa (19)
Japan (297)
Kansas (119)
Kentucky (34)
Louisiana (17)
Maine (67)
Maryland (1190)
Massachusetts (6706)
Michigan (275)
Minnesota (527)
Mississippi (4)
Missouri (105)
Montana (31)
Nebraska (25)
Nevada (101)
New Hampshire (73)
New Jersey (2473)
New Mexico (30)
New York (2448)
North Carolina (1295)
North Dakota (9)
Northern California (4099)
Ohio (270)
Oklahoma (18)
Oregon (40)
Pennsylvania (1890)
Puerto Rico (18)
Rhode Island (44)
South America (1113)
South Carolina (44)
South Dakota (1)
Southern California (3467)
Tennessee (144)
Texas (1384)
United States (32927)
Utah (263)
Virginia (220)
Washington D.C. (76)
Washington State (764)
West Virginia (4)
Wisconsin (79)
Wyoming (1)
727,538 Results for "sirna therapeutics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
Arrowhead Nabs up to $2B Novartis Commitment for siRNA Parkinson’s Program
Novartis is licensing ARO-SNCA, a preclinical siRNA therapy for synucleinopathies, a group of neurodegenerative disorders including Parkinson’s disease.
September 2, 2025
·
1 min read
·
Annalee Armstrong
Press Releases
Rona Therapeutics Announces IND Filing of RN3161, a Highly Potent and Durable INHBE siRNA for Obesity
September 16, 2025
·
2 min read
Press Releases
Sarepta Therapeutics Announces Advancement of siRNA Collaboration and Sale of Arrowhead Equity Investment
August 13, 2025
·
5 min read
Press Releases
CRISPR Therapeutics and Sirius Therapeutics Announce Multi-Target Collaboration to Develop Novel siRNA Therapies
May 20, 2025
·
10 min read
Drug development
siRNA on the Precipice as Candidates Reach Beyond the Liver
As multiple companies vie to expand on Alnylam’s success in commercializing RNAi therapeutics, the pioneering company has set a goal of targeting small interfering RNA to any tissue by 2030.
June 9, 2025
·
7 min read
·
Shawna Williams
Press Releases
Mabwell Bioscience and Aditum Bio Announce Formation of Kalexo Bio to Advance Innovative siRNA Therapy for Cardiovascular Disorders
September 18, 2025
·
3 min read
C-suite
Zhen Li: A Reluctant Engineer Shaping the World of siRNA
ADARx Pharmaceuticals CEO Zhen Li found her way to biopharma through Merck, where she was inspired by the application of powerful science to human medicine.
July 23, 2025
·
4 min read
·
Annalee Armstrong
Press Releases
Phio Pharmaceuticals to Present at the Life Sciences Future Conference
Key updates to include advances made in the on-going clinical trial for INTASYL siRNA lead product candidate PH-762
September 18, 2025
·
4 min read
Press Releases
Aro Biotherapeutics Completes Enrollment in Phase 1b Trial of Targeted siRNA Therapy, ABX1100, in Late-Onset Pompe Disease (LOPD)
September 25, 2025
·
4 min read
Collaboration
CRISPR Expands Focus, Pays Up To $95M in Sirius’ siRNA Pact
The partnership with Sirius expands CRISPR Therapeutics’ modality toolkit, especially in the cardiovascular space.
May 20, 2025
·
2 min read
·
Tristan Manalac
1 of 72,754
Next
